-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.30150% Upside
Akoya Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Akoya Biosciences, Inc.?
Akoya Biosciences, Inc. has been rated by research analysts at Piper Sandler, Morgan Stanley, Craig-Hallum, BTIG, Canaccord Genuity in the past 90 days.